Letters to the Editor

A novel BCMA CAR-T-cell therapy with optimized human scFv for treatment of relapsed/refractory multiple myeloma: results from phase I clinical trials

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China; CARsgen Therapeutics Co. Ltd, Shanghai
CARsgen Therapeutics Co. Ltd, Shanghai
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
CARsgen Therapeutics Co. Ltd, Shanghai
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
CARsgen Therapeutics Corp., Houston, TX
CARsgen Therapeutics Co. Ltd, Shanghai
CARsgen Therapeutics Co. Ltd, Shanghai
CARsgen Therapeutics Corp., Houston, TX
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
CARsgen Therapeutics Co. Ltd, Shanghai, China; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
Haematologica Early view Apr 21, 2022 https://doi.org/10.3324/haematol.2022.280629